Home Cart 0 Sign in  

[ CAS No. 1425045-01-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1425045-01-7
Chemical Structure| 1425045-01-7
Structure of 1425045-01-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1425045-01-7 ]

Related Doc. of [ 1425045-01-7 ]

Alternatived Products of [ 1425045-01-7 ]

Product Details of [ 1425045-01-7 ]

CAS No. :1425045-01-7 MDL No. :MFCD16996317
Formula : C13H20BNO3 Boiling Point : -
Linear Structure Formula :- InChI Key :WYLZKEAKTKRGKT-UHFFFAOYSA-N
M.W : 249.11 Pubchem ID :71270309
Synonyms :

Calculated chemistry of [ 1425045-01-7 ]

Physicochemical Properties

Num. heavy atoms : 18
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.62
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 73.41
TPSA : 40.46 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.9 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 1.3
Log Po/w (WLOGP) : 0.99
Log Po/w (MLOGP) : 1.01
Log Po/w (SILICOS-IT) : 1.38
Consensus Log Po/w : 0.94

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.38
Solubility : 1.03 mg/ml ; 0.00413 mol/l
Class : Soluble
Log S (Ali) : -1.75
Solubility : 4.43 mg/ml ; 0.0178 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.49
Solubility : 0.0814 mg/ml ; 0.000327 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.07

Safety of [ 1425045-01-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1425045-01-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1425045-01-7 ]
  • Downstream synthetic route of [ 1425045-01-7 ]

[ 1425045-01-7 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 51417-13-1 ]
  • [ 73183-34-3 ]
  • [ 1425045-01-7 ]
YieldReaction ConditionsOperation in experiment
100% With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; potassium acetate In 1,4-dioxane; water at 85℃; for 16 h; Inert atmosphere Nitrogene was passed through dioxane and this solution ( 2.0 mL) was then added to a mixture of the 5-bromo-1,3-dimethylpyridin-2(1H)-one (75 mg, 0.37 mmol), bis(pinacolato)diboron ( 113 mg, 0.445 mmol) and KOAc (109 mg, 1.11 mmol) followed by the addition of the catalyst PdCl2(dppf).CH2Cl2 (30 mg, 0.037 mmol). The reaction mixture was heated at 85 oC for 16 hours then diluted with EtOAc and and filtered on a pad of Celite®. The filtrate was concentrated under vacuum, resulting in the crude title compound (169 mg, 0.678 mmol, quantitative yield) as brown oil.
Reference: [1] Patent: WO2016/196644, 2016, A1, . Location in patent: Paragraph 709; 710
[2] Journal of Medicinal Chemistry, 2016, vol. 59, # 10, p. 4462 - 4475
[3] Patent: WO2014/78323, 2014, A1, . Location in patent: Paragraph 00584
[4] Patent: US2018/44335, 2018, A1, . Location in patent: Paragraph 0459-0460
[5] Patent: WO2018/102452, 2018, A2, . Location in patent: Paragraph 693; 694
  • 2
  • [ 6456-92-4 ]
  • [ 73183-34-3 ]
  • [ 1425045-01-7 ]
YieldReaction ConditionsOperation in experiment
81% With [2,2]bipyridinyl; (1,5-cyclooctadiene)(methoxy)iridium(I) dimer In 1,4-dioxane at 40℃; for 4 h; Inert atmosphere; Schlenk technique General procedure: Ligand (0.010 mmol) and [Ir(OMe)(cod)]2 (3.3 mg, 0.0050 mmol) were placed in a 20-mL two-necked reaction flask, which was filled with N2 by using the standard Schlenk technique. Solvent (0.50 mL) was injected via a syringe, and the mixture was stirred for 5 min at r.t. A solution of 2-pyridone (0.25 mmol) and bis(pinacolato)diboron(0.38–0.75 mmol) in solvent (1.0 mL) was then added, and the suspension was stirred under the indicated conditions. The resulting mixture was allowed to cool to r.t., diluted with EtOAc, and filtered through a short pad of neutral alumina and anhyd Na2SO4. After concentration under reduced pressure, purification by GPC (EtOAc) afforded the corresponding borylated 2-pyridone.
Reference: [1] Synthesis (Germany), 2017, vol. 49, # 21, p. 4745 - 4752
  • 3
  • [ 89488-30-2 ]
  • [ 1425045-01-7 ]
Reference: [1] Patent: US2018/44335, 2018, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1425045-01-7 ]

Organoboron

Chemical Structure| 1002309-52-5

[ 1002309-52-5 ]

1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one

Similarity: 0.90

Chemical Structure| 1160790-84-0

[ 1160790-84-0 ]

1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one

Similarity: 0.82

Chemical Structure| 935660-75-6

[ 935660-75-6 ]

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide

Similarity: 0.82

Chemical Structure| 1256358-90-3

[ 1256358-90-3 ]

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one

Similarity: 0.80

Chemical Structure| 1313399-38-0

[ 1313399-38-0 ]

2-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one

Similarity: 0.79

Amides

Chemical Structure| 1002309-52-5

[ 1002309-52-5 ]

1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one

Similarity: 0.90

Chemical Structure| 1160790-84-0

[ 1160790-84-0 ]

1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one

Similarity: 0.82

Chemical Structure| 935660-75-6

[ 935660-75-6 ]

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide

Similarity: 0.82

Chemical Structure| 1256358-90-3

[ 1256358-90-3 ]

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one

Similarity: 0.80

Chemical Structure| 1313399-38-0

[ 1313399-38-0 ]

2-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one

Similarity: 0.79

Related Parent Nucleus of
[ 1425045-01-7 ]

Pyridines

Chemical Structure| 1002309-52-5

[ 1002309-52-5 ]

1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one

Similarity: 0.90

Chemical Structure| 1160790-84-0

[ 1160790-84-0 ]

1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one

Similarity: 0.82

Chemical Structure| 1256358-90-3

[ 1256358-90-3 ]

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one

Similarity: 0.80

Chemical Structure| 1201645-46-6

[ 1201645-46-6 ]

N-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)acetamide

Similarity: 0.70

Chemical Structure| 1201644-47-4

[ 1201644-47-4 ]

Morpholino(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)methanone

Similarity: 0.68